Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer G Serna, F Ruiz-Pace, J Hernando, L Alonso, R Fasani, S Landolfi, ... Annals of Oncology 31 (10), 1366-1375, 2020 | 84 | 2020 |
Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994–2013) R Fuentes-Raspall, M Solans, A Roca-Barceló, L Vilardell, M Puigdemont, ... Cancer epidemiology 50, 1-8, 2017 | 51 | 2017 |
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer E Elez, J Ros, J Fernández, G Villacampa, AB Moreno-Cárdenas, ... Nature medicine 28 (10), 2162-2170, 2022 | 47 | 2022 |
Integración de herramientas de control de gestión para el alineamiento estratégico en el sistema empresarial cubano. Aplicación en empresas de Sancti Spiritus R Comas MSc. Tesis, 2013 | 24 | 2013 |
Gestión del cambio y Dirección Estratégica V Vega, R Comas Quito: El siglo, 2017 | 22 | 2017 |
Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments J Ros, J Matito, G Villacampa, R Comas, A Garcia, G Martini, I Baraibar, ... Annals of Oncology 34 (6), 543-552, 2023 | 20 | 2023 |
Incidence and survival of Hodgkin lymphoma patients in Girona (Spain) over three decades: a population-based study M Solans, L Serra, G Renart, G Osca-Gelis, R Comas, L Vilardell, ... European Journal of Cancer Prevention 26, S164-S169, 2017 | 12 | 2017 |
La investigación científica y las formas de titulación, aspectos conceptuales y prácticos A Romero, F Castro, G Álvarez, M Velázquez, R Comas, V Falcon Ecuador: Universidad Regional Autónoma de los Andes, 2017 | 11 | 2017 |
LBA-3 Integrated analysis of cell-free DNA (cfDNA) BRAF mutant allele fraction (MAF) and whole exome sequencing in BRAFV600E metastatic colorectal cancer (mCRC) treated with … E Élez, J Ros, G Martini, J Matito, G Villacampa, F Salva, I Baraibar, ... Annals of Oncology 32, S226-S227, 2021 | 10 | 2021 |
Patient and tumor characteristics as determinants of overall survival (OS) in BRAF V600 mutant (mt) metastatic colorectal cancer (mCRC) treated with doublet or … J Ros Montañá, G Martini, I Baraibar, G Villacampa, R Comas, ... Journal of Clinical Oncology 38 (15_suppl), 4112-4112, 2020 | 10 | 2020 |
Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain M Solans, G Osca-Gelis, R Comas, JM Roncero, D Gallardo, ... Cancer Causes & Control 29, 379-382, 2018 | 9 | 2018 |
A Comprehensive Biomarker analysis of microsatellite Unstable/Mismatch repair deficient colorectal Cancer cohort treated with immunotherapy E Élez, N Mulet-Margalef, M Sanso, F Ruiz-Pace, FM Mancuso, R Comas, ... International Journal of Molecular Sciences 24 (1), 118, 2022 | 3 | 2022 |
Young-onset colorectal cancer: A call for action. I Baraibar, F Salva, R Comas, J Ros, A Garcia, M Sanchis, JL Cuadra, ... Journal of Clinical Oncology 39 (15_suppl), 10563-10563, 2021 | 2 | 2021 |
Mortality of women with ductal carcinoma in situ of the breast: A population-based study from the Girona province, Spain (1994–2013) A Roca-Barceló, G Viñas, H Pla, A Carbó, R Comas, Á Izquierdo, ... Clinical and Translational Oncology 21, 891-899, 2019 | 2 | 2019 |
Impact of the COVID-19 pandemic in the early-onset colorectal cancer I Baraibar, A García, F Salvà, J Ros, N Saoudi, R Comas, G Castillo, ... Translational Oncology 32, 101668, 2023 | 1 | 2023 |
426P Spotlight on refractory metastatic colorectal cancer (refMCRC): Role of prognostic characteristics in the continuum of care AA Valdivia, F Salva, J Ros, I Baraibar, GA Martinez, NS Gonzalez, ... Annals of Oncology 32, S547-S548, 2021 | 1 | 2021 |
445P Tumor load surrogates as major prognostic factors in BRAF-V600E mutated (mt) colorectal (CRC) patients treated with BRAF inhibitor+ antiEGFR+/-MEK inhibitor FJR Montana, G Martini, GV Javierre, I Baraibar, R Comas, A Garcia, ... Annals of Oncology 32, S556, 2021 | 1 | 2021 |
461P Molecular tumor profiling and matched molecular targeted treatment in metastatic young-onset colorectal cancer (YOCR) IB Argota, J Ros, R Comas, S Aguilar, F Salva, A Garcia, JLC Urteaga, ... Annals of Oncology 32, S562-S563, 2021 | 1 | 2021 |
Mucinous differentiation (MD) as predictor of response in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with BRAF inhibitors (BRAFi) combinations FJ Ros Montana, V Navarro, R Comas, S Landolfi, L Ramirez, HG Palmer, ... ANNALS OF ONCOLOGY 34, S447-S447, 2023 | | 2023 |
626P Mucinous differentiation (MD) as predictor of response in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with BRAF inhibitors (BRAFi) combinations FJR Montana, V Navarro, R Comas, S Landolfi, L Ramirez, HG Palmer, ... Annals of Oncology 34, S447, 2023 | | 2023 |